Remdesivir in adults with severe COVID-19 : a randomised, double-blind, placebo-controlled, multicentre trial /

Remdesivir in adults with severe COVID-19 : a randomised, double-blind, placebo-controlled, multicentre trial / Yeming Wang [and forty one others]

In: The Lancet, 2020 Vol. 395 (10236) page 1569-1578


Nucleosides
Prodrugs
Coronavirus

Remdesivir COVID-19